Company / Cash per Share
Mineralys Therapeutics, Inc. Cash per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$2.35
FY2024
5-year range
$1.36 / $16.97
FY2022-FY2024
Trend
+72.5%
vs FY2023
Sector context
#92 of 205
Health Care
What the data says
At $2.35, Mineralys Therapeutics, Inc.'s cash per share ranks #92 of 205 in the Health Care sector. Declined from $16.97 to $2.35 over the past 2 years.
Based on SEC 10-K filings.
2.35 in FY2024.
Declined from $16.97 to $2.35 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#92 of 205 in Health CareTop 45% of 205This company $2.35 Sector average $72.93
▼
-96.8% below sector average
Key checks
Key Insights
- In FY2024, cash per share increased 72.5% year-over-year.
- Ranks #92 out of 205 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.35 | +72.5% |
| FY2023 | $1.36 | -92.0% |
| FY2022 | $16.97 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026